Hennion & Walsh Asset Management’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,265
| Closed | -$550K | – | 932 |
|
|
2025
Q1 | $550K | Sell |
1,265
-101
| -7% | -$43.9K | 0.02% | 609 |
|
|
2024
Q4 | $504K | Sell |
1,366
-1,421
| -51% | -$524K | 0.02% | 618 |
|
|
2024
Q3 | $1.45M | Sell |
2,787
-1,049
| -27% | -$545K | 0.07% | 363 |
|
|
2024
Q2 | $2.08M | Sell |
3,836
-2,300
| -37% | -$1.25M | 0.11% | 243 |
|
|
2024
Q1 | $3.18M | Sell |
6,136
-1,319
| -18% | -$684K | 0.17% | 159 |
|
|
2023
Q4 | $3.52M | Sell |
7,455
-4,002
| -35% | -$1.89M | 0.2% | 131 |
|
|
2023
Q3 | $4.99M | Sell |
11,457
-2,942
| -20% | -$1.28M | 0.32% | 62 |
|
|
2023
Q2 | $6.4M | Sell |
14,399
-1,364
| -9% | -$606K | 0.38% | 49 |
|
|
2023
Q1 | $7.25M | Buy |
15,763
+472
| +3% | +$217K | 0.44% | 45 |
|
|
2022
Q4 | $7.84M | Sell |
15,291
-1,519
| -9% | -$779K | 0.48% | 41 |
|
|
2022
Q3 | $7.64M | Buy |
16,810
+1,890
| +13% | +$859K | 0.5% | 43 |
|
|
2022
Q2 | $7.2M | Buy |
14,920
+2,297
| +18% | +$1.11M | 0.45% | 49 |
|
|
2022
Q1 | $6.2M | Buy |
12,623
+784
| +7% | +$385K | 0.33% | 73 |
|
|
2021
Q4 | $5.49M | Buy |
11,839
+4,084
| +53% | +$1.89M | 0.27% | 100 |
|
|
2021
Q3 | $2.89M | Buy |
7,755
+1,466
| +23% | +$547K | 0.15% | 195 |
|
|
2021
Q2 | $2.4M | Buy |
6,289
+2,832
| +82% | +$1.08M | 0.13% | 216 |
|
|
2021
Q1 | $1.24M | Buy |
+3,457
| New | +$1.24M | 0.07% | 313 |
|